Jana Davidson
Program: Child & Adolescent Psychiatry
Contact info
Professional Affiliations and other Positions
Research and Interests
Metabolic Effects of Psychotropic Medications
Biography
Jana Davidson is Vice-President Medical Affairs & Psychiatrist in Chief, Children’s & Women’s Mental Health Programs, PHSA, an Associate Clinical Professor, Dept of Psychiatry, University of British Columbia and Head of the Division of Child & Adolescent Psychiatry at UBC. Jana completed both her medical training and psychiatric residency at the University of British Columbia and her Child & Adolescent Psychiatry Fellowship at BC Children’s Hospital and the Early Psychosis Intervention Program in Melbourne, Australia. In 2001, she received the Postgraduate Teaching Award in Psychiatry and in 2004, she received the University of British Columbia Department of Psychiatry Excellence in Undergraduate Teaching Award. At present, Dr. Davidson consults to the new provincial Child & Adolescent Mental Health Metabolic Clinic, the Urgent Assessment Clinic at BC Children’s Hospital and the Provincial Child and Adolescent Eating Disorders Program. Her research interests include the metabolic effects of second generation antipsychotics on children and youth.
Selected Publications
• Ronsley R, Rayter M, Smith DH, Davidson JL, Panagiotopoulos C. Metabolic monitoring training program implementation in the community setting was associated with improved monitoring in second-generation antipsychotic-treated children. Canadian Journal Psychiatry (May 2012).
• Horn, M., Procyshyn, RM., Warburton, WP, Tregillus, V., Cavers, W., Davidson, JL. Second-Generation Antipsychotic Prescribing in Adults and Children: Best Practice Recommendations for General Practitioners. British Columbia Medical Journal (March 2012).
• Panagiotopoulos C, Ronsley, R, Kuzeljevic B, Davidson JL. Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics. Canadian Journal Psychiatry (January 2012).
• Pringsheim T., Panagiotopoulos C, Davidson JL, Ho J. for the CAMESA Guideline Group. Evidence-based Recommendations for Monitoring Safety of Second Generation Antipsychotics in Children and Youth. Journal Canadian Academy of Child & Adolescent Psychiatry (August, 2011).
• Ronsley R, Raghuram K, Davidson JL. Panagiotopoulos C. Barriers and Facilitators to Implementation of a Metabolic Monitoring Protocol in Hospital and Community Settings for Second-Generation Antipsychotic-Treated Youth. Journal Canadian Academy of Child & Adolescent Psychiatry (May, 2011).